Advisor Group’s NxStage Medical Inc. NXTM Stock Holding History

Advisor Group’s Portfolio NXTM Stock Details NXTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-100	Closed	-$3K	–	5458
2018 Q4	$3K	Hold	100	–	–	﹤0.01%	4774
2018 Q3	$3K	Sell	100 -2,000	-95%	-$56.2K	﹤0.01%	4796
2018 Q2	$59K	Buy	2,100 +100	+5%	+$2.68K	﹤0.01%	2961
2018 Q1	$50K	Hold	2,000	–	–	﹤0.01%	3070
2017 Q4	$48K	Buy	+2,000	New	+$52.7K	﹤0.01%	3116
2017 Q3	–	Sell	-316	Closed	-$9K	–	5045
2017 Q2	$9K	Buy	316 +3	+1%	+$74	﹤0.01%	4017
2017 Q1	$9K	Buy	313 +213	+213%	+$5.88K	﹤0.01%	3876
2016 Q4	$3K	Hold	100	–	–	﹤0.01%	4170
2016 Q3	$2K	Hold	100	–	–	﹤0.01%	4236
2016 Q2	$2K	Buy	+100	New	+$1.78K	﹤0.01%	4160

Other funds holding NXTM

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Advisor Group's NXTM Position: Q1 2019 in Review

Advisor Group sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 100 shares — an estimated $3K sold.

Advisor Group first reported a position in NXTM in Q2 2016 and held it in 10 quarters. The position peaked at $59K in Q2 2018. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.

Advisor Group reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
Advisor Group sold 100 NxStage Medical Inc. shares in Q1 2019, an estimated $3K.
Advisor Group first reported a position in NxStage Medical Inc. in Q2 2016 and held it in 10 quarters.
Advisor Group's NxStage Medical Inc. position peaked at $59K in Q2 2018.
1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.

Based on Advisor Group's 13F filing for Q1 2019, filed 9 May 2019.